Lith, Netherlands

Tom Beetz


Average Co-Inventor Count = 1.6

ph-index = 3

Forward Citations = 38(Granted Patents)


Company Filing History:


Years Active: 1987-1989

Loading Chart...
3 patents (USPTO):Explore Patents

Title: Tom Beetz: Innovator in Glycobiology

Introduction

Tom Beetz is a notable inventor based in Lith, Netherlands. He has made significant contributions to the field of glycobiology, particularly through his innovative research and patented inventions. With a total of 3 patents, Beetz has focused on developing compounds with therapeutic applications.

Latest Patents

One of Beetz's latest patents involves pentasaccharides and tetrasaccharides that exhibit anti-thrombotic activity. This invention addresses new pentasaccharides of a specific formula, which demonstrate potent anti-Xa activity and inactivate thrombin via HC-II, while not affecting thrombin through AT-III. Additionally, he has developed new tetrasaccharides that serve as intermediates in the synthesis of these pentasaccharides. Another significant patent pertains to disaccharide and trisaccharide derivatives of the lipid A type, which possess interesting immuno-modulating and immuno-stimulating properties.

Career Highlights

Throughout his career, Tom Beetz has worked with prominent companies such as Akzo N.V. and Sanofi S.A. His work in these organizations has allowed him to further his research and contribute to advancements in the field of glycobiology.

Collaborations

Beetz has collaborated with esteemed colleagues, including Constant A Van Boeckel and Maurice Petitou. These partnerships have enriched his research and led to innovative discoveries in his field.

Conclusion

Tom Beetz is a distinguished inventor whose work in glycobiology has led to valuable patents and advancements in therapeutic applications. His contributions continue to impact the scientific community positively.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…